Tip of the Month
Publishing date: November 2019
Tip Editors: Frances Meier-Gibbons, Humma Shahid, Karl Mercieca, Francisco Goni
Tip reviewer: Roger Hitchings
The Science behind the Tip
Clinical trials have shown us average rates of progression and average ideal IOP readings for populations of patients but there is great variability in the natural history of glaucomatous disease which cannot be prospectively predicted with accuracy in an individual patient.
Studies suggest that adherence to follow up schedules may favorably impact the course of glaucomatous disease. Patients should not have a false sense of security that simply taking their medications will prevent their disease from progressing.
Contributor: Kuldev Singh, MD Stanford University, USA
Ung C, Murakami Y, Zhang E, Alfaro T, Zhang M, Seider MI, Singh K, Lin SC. The Association Between Compliance With Recommended Follow-up and Glaucomatous Disease Severity in a County Hospital Population. American Journal of Ophthalmology. 2013 Aug; 156(2):362-369.
Ung C, Zhang E, Alfaro T, Murakami Y, Zhang M, Seider MI, Lin SC, Singh K. Glaucoma Severity and Medication Adherence in a County Hospital Population. Ophthalmology. 2013 Jun; 120(6):1150-7.